Walnut Consumption and Diabetes Risk

Sponsor
University of California, Los Angeles (Other)
Overall Status
Completed
CT.gov ID
NCT03224533
Collaborator
California Walnut Commission (Other)
34,121
1
24
1424.6

Study Details

Study Description

Brief Summary

Multiple NHANES surveys were combined and weighted to evaluate relationships between walnut consumption and type 2 diabetes mellitus using various independent measures of diabetes status and risk. After risks were ascertained, interactions with gender were analyzed.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Diabetes Outcome

Detailed Description

Background. Dietary interventions and cohort studies of tree nuts lowering glucose levels for diabetes suggest a possible effect with walnuts. Objective. To examine the associations between walnut consumption and diabetes risk through data from the National Health and Nutrition Examination Survey (NHANES). Methods. NHANES survey data for 1999 through 2014 was pooled for adults with 24 hour recall dietary data. Risk of diabetes was based on self-report, medication use, fasting plasma glucose levels, and hemoglobin A1c (HbA1c) levels. Individuals were characterized as reporting consumption of walnuts, mixed 'nuts', or no nuts.

Study Design

Study Type:
Observational
Actual Enrollment :
34121 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Association Between Walnut Consumption and Diabetes Risk in NHANES May be Gender Sex Specific
Actual Study Start Date :
Jun 1, 2015
Actual Primary Completion Date :
May 30, 2017
Actual Study Completion Date :
May 30, 2017

Arms and Interventions

Arm Intervention/Treatment
No Nuts

All other foods that did not include walnuts or other nuts were classified as "no nuts" (NN).

Diagnostic Test: Diabetes Outcome
based on self report definition, fasting plasma glucose, and hemoglobin A1c

Other Nuts

Foods codes describing nuts that are not walnuts (i.e. cashew nuts, pistachios, etc.) or nut-containing foods that do not commonly contain walnuts (e.g. granola) were classified as "other nuts" (ON).

Diagnostic Test: Diabetes Outcome
based on self report definition, fasting plasma glucose, and hemoglobin A1c

Walnuts with other nuts

food codes describing nut mixes and foods that commonly include walnuts were classified as "walnuts with other nuts" (WwON)

Diagnostic Test: Diabetes Outcome
based on self report definition, fasting plasma glucose, and hemoglobin A1c

Walnuts with high certainty

Foods consisting entirely or mostly of walnuts were classified as "walnuts with high certainty" (WwHC)

Diagnostic Test: Diabetes Outcome
based on self report definition, fasting plasma glucose, and hemoglobin A1c

Outcome Measures

Primary Outcome Measures

  1. Diabetes Outcome- self report [1999-2014]

    Based on self-report as told by a doctor

  2. Diabetes Outcome- Fasting Plasma Glucose [1999-2014]

    Based on FPG levels

  3. Diabetes Outcome- Hemoglobin A1c [1999-2014]

    Based on HbA1c levels

  4. Diabetes Outcome- Combined Definition [1999-2014]

    Based on both FPG and HbA1c levels

Secondary Outcome Measures

  1. Sex Interaction [1999-2014]

    based on the previously stated definition outcomes

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • NHANES data from 1999-2014 with food recalls and dietary food intake
Exclusion Criteria:
  • not having data on either day of the 24-hour food intake

  • individuals who consumed peanuts, but not other nuts on the day of recall, were excluded from the analysis

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of California Los Angeles Los Angeles California United States 90095

Sponsors and Collaborators

  • University of California, Los Angeles
  • California Walnut Commission

Investigators

  • Principal Investigator: Lenore Arab, MSc, PhD, David Geffen School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Lenore Arab, PhD, Principal Investigator, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT03224533
Other Study ID Numbers:
  • WALNUT6DIABETES
First Posted:
Jul 21, 2017
Last Update Posted:
Jul 21, 2017
Last Verified:
Jul 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lenore Arab, PhD, Principal Investigator, University of California, Los Angeles
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 21, 2017